UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.556

Sortiert nach

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions

Journal of neurology, 2023-11, Vol.270 (11), p.5671-5673

2023

Link zum Volltext

Verfügbarkeit prüfen

A role for the Epstein–Barr virus in multiple sclerosis aetiology?

Journal of neurology, 2022-07, Vol.269 (7), p.3962-3963

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical patterns in CADASIL

Journal of neurology, 2022-08, Vol.269 (8), p.4575-4577

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials in myasthenia gravis

Journal of neurology, 2023-09, Vol.270 (9), p.4579-4581

2023

Link zum Volltext

Verfügbarkeit prüfen

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2

Journal of neurology, 2021-05, Vol.268 (5), p.2002-2004

2021

Link zum Volltext

Verfügbarkeit prüfen

Cerebral venous thrombosis: clinical predictors and emerging treatments

Journal of neurology, 2020-10, Vol.267 (10), p.3112-3114

2020

Link zum Volltext

Verfügbarkeit prüfen

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts

Journal of neurology, 2020-07, Vol.267 (7), p.2173-2175

2020

Link zum Volltext

Verfügbarkeit prüfen

Cerebral amyloid angiopathy: an update

Journal of neurology, 2023-05, Vol.270 (5), p.2809-2811

2023

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis: early indicators of disease and assessing future risk

Journal of neurology, 2020-11, Vol.267 (11), p.3436-3438

2020

Link zum Volltext

Verfügbarkeit prüfen

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

Multiple sclerosis, 2012-10, Vol.18 (10), p.1401-1411

2012

Link zum Volltext

Verfügbarkeit prüfen

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

Journal of neurology, neurosurgery and psychiatry, 2009-03, Vol.80 (3), p.292-296

2009

Link zum Volltext

Verfügbarkeit prüfen

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Clinical and experimental immunology, 2009-02, Vol.155 (2), p.128-139

2009

Link zum Volltext

Verfügbarkeit prüfen

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

Multiple sclerosis, 2012-01, Vol.18 (1), p.45-54

2012

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

Multiple sclerosis, 2016-08, Vol.22 (9), p.1215-1223

2016

Link zum Volltext

Verfügbarkeit prüfen

Technology-assisted recovery of walking after spinal cord injury

Journal of neurology, 2019-04, Vol.266 (4), p.1046-1048

2019

Link zum Volltext

Verfügbarkeit prüfen

Increasing prevalence and incidence of multiple sclerosis in South East Wales

Journal of neurology, neurosurgery and psychiatry, 2009-04, Vol.80 (4), p.386-391

2009

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

Journal of neurology, 2020-05, Vol.267 (5), p.1567-1569

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2009-07, Vol.80 (7), p.805-807

2009

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab for multiple sclerosis: a new age of immunotherapy

Journal of neurology, 2013, Vol.260 (1), p.343-345

Robertson, N. P.

2013

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic status in neurological disorders: a modifiable risk factor?

Journal of neurology, 2022-06, Vol.269 (6), p.3385-3386

2022

Link zum Volltext

Verfügbarkeit prüfen

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Journal of neurology, 2022-01, Vol.269 (1), p.534-536

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment

Journal of neurology, 2021-11, Vol.268 (11), p.4396-4397

2021

Link zum Volltext

Verfügbarkeit prüfen

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Journal of neurology, 2008-02, Vol.255 (2), p.231-238

2008

Link zum Volltext

Verfügbarkeit prüfen

Neurological complications of COVID-19: a preliminary review

Journal of neurology, 2020-06, Vol.267 (6), p.1870-1873

2020

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

Journal of neurology, 2010-06, Vol.257 (6), p.913-919

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.556

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.145)
Mit Volltextzugriff
(3.216)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.278)
Life Sciences & Biomedicine
(1.465)
Humans
(1.188)
Female
(719)
Biological And Medical Sciences
(702)
Physical Sciences
(664)
Male
(626)
Medical Sciences
(557)
Physics
(484)
Adult
(426)
Middle Aged
(356)
Animals
(334)
Astronomy & Astrophysics
(266)
Aged
(231)
Neurosciences & Neurology
(213)
Technology
(207)
Adolescent
(201)
Fundamental And Applied Biological Sciences. Psychology
(194)
Physics, Particles & Fields
(188)
Child
(173)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek (Open access)
(1.683)
MEDLINE
(1.466)
Ingenta E-Journals
(1.396)
Ovid SocietyJournals and Single Titles
(1.103)
NUS Single-Journal Subscriptions
(1.088)
Elsevier ScienceDirect Journals Complete
(692)
IngentaConnect Journals
(530)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(516)
Wiley Online Library Journals
(414)
SpringerLink
(353)
APS: American Physical Society E-Journals (Physics)
(332)
American Physical Society [PROLA]
(308)
Wiley Online Library
(267)
Oxford Journals
(199)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(189)
Nature_系列刊
(182)
JSTOR
(180)
Oxford Journals 2020 Medicine
(138)
Nexis
(105)
BMJ Journals
(103)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions

A role for the Epstein–Barr virus in multiple sclerosis aetiology?

Clinical patterns in CADASIL

Clinical trials in myasthenia gravis

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2

Cerebral venous thrombosis: clinical predictors and emerging treatments

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts

Cerebral amyloid angiopathy: an update

Multiple sclerosis: early indicators of disease and assessing future risk

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

Complement in multiple sclerosis: its role in disease and potential as a biomarker

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

Technology-assisted recovery of walking after spinal cord injury

Increasing prevalence and incidence of multiple sclerosis in South East Wales

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis

Alemtuzumab for multiple sclerosis: a new age of immunotherapy

Socioeconomic status in neurological disorders: a modifiable risk factor?

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Neurological complications of COVID-19: a preliminary review

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

Suchergebnisse filtern